Cancer patients' first treatment episode with opioids: A pharmaco-epidemiological perspective
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Cancer patients' first treatment episode with opioids : A pharmaco-epidemiological perspective. / Jarlbaek, Lene; Hallas, Jesper; Kragstrup, Jakob; Andersen, Morten.
I: Supportive Care in Cancer, Bind 14, Nr. 4, 04.2006, s. 340-347.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cancer patients' first treatment episode with opioids
T2 - A pharmaco-epidemiological perspective
AU - Jarlbaek, Lene
AU - Hallas, Jesper
AU - Kragstrup, Jakob
AU - Andersen, Morten
N1 - Funding Information: This study was supported by grants from the Danish Cancer Society. There is no conflict of interest.
PY - 2006/4
Y1 - 2006/4
N2 - Goal: The factors underlying the choice of opioids for cancer patients in primary care are largely unknown. Our aim was to describe cancer patients' first treatment episode with opioids in relation to disease characteristics and clinical course. Patients and methods: During 1997 and 1998, a population-based cohort of 4,006 incident cancer patients from a Danish county was identified. The patients were followed up from diagnosis to death or until 31 December 2003, and data on their use of opioids were obtained from a prescription database. Main results: Eventually, 54% of the cancer patients became incident users of opioids. Opioid treatment was initiated close to the diagnosis date in 20% of the patients. Most incident users (57%) were not terminal when they began using opioids, and 44% survived the first treatment episode. Of those who died, 70% received opioids in their terminal phase. The incidence rates of new opioid users were inversely related to the 5-year cancer survival period. A weak opioid was the first choice in 64% of the non-terminal users and in 43% of the terminal ones. No statistically significant differences in opioid use were found between men and women. Conclusions: Opioid use in cancer patients was not confined to the terminal course. Treatment with opioids should be viewed as a dynamic condition, with patients shifting between periods of use and non-use. The aggressiveness of the cancer and the presence of metastases were characteristics found to be strong determinants of opioid use.
AB - Goal: The factors underlying the choice of opioids for cancer patients in primary care are largely unknown. Our aim was to describe cancer patients' first treatment episode with opioids in relation to disease characteristics and clinical course. Patients and methods: During 1997 and 1998, a population-based cohort of 4,006 incident cancer patients from a Danish county was identified. The patients were followed up from diagnosis to death or until 31 December 2003, and data on their use of opioids were obtained from a prescription database. Main results: Eventually, 54% of the cancer patients became incident users of opioids. Opioid treatment was initiated close to the diagnosis date in 20% of the patients. Most incident users (57%) were not terminal when they began using opioids, and 44% survived the first treatment episode. Of those who died, 70% received opioids in their terminal phase. The incidence rates of new opioid users were inversely related to the 5-year cancer survival period. A weak opioid was the first choice in 64% of the non-terminal users and in 43% of the terminal ones. No statistically significant differences in opioid use were found between men and women. Conclusions: Opioid use in cancer patients was not confined to the terminal course. Treatment with opioids should be viewed as a dynamic condition, with patients shifting between periods of use and non-use. The aggressiveness of the cancer and the presence of metastases were characteristics found to be strong determinants of opioid use.
KW - Cancer patients
KW - Cohort study
KW - Opioids
KW - Pain treatment
KW - Sex differences
UR - http://www.scopus.com/inward/record.url?scp=33646435541&partnerID=8YFLogxK
U2 - 10.1007/s00520-005-0890-8
DO - 10.1007/s00520-005-0890-8
M3 - Journal article
C2 - 16187053
AN - SCOPUS:33646435541
VL - 14
SP - 340
EP - 347
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
SN - 0941-4355
IS - 4
ER -
ID: 324144606